[1] Mack U, Migliori GB, Sester M, et al. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J, 2009; 33, 956. doi:  10.1183/09031936.00120908
[2] Dye C, Scheele S, Dolin P, et al. Global Burden of Tuberculosis: Estimated Incidence, Prevalence, and Mortality by Country. JAMA, 1999; 282, 1189-210. https://jamanetwork.com/journals/jama/fullarticle/191271
[3] Hirsch-Moverman Y, Daftary A, Franks J, et al. Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada. Int J Tuberclung D, 2009; 12, 1235. https://www.researchgate.net/profile/Amrita_Daftary/publication/23388352_Adherence_to_treatment_for_latent_tuberculosis_infection_Systematic_review_of_studies_in_the_US_and_Canada/links/558045e508aea3d7096e4613.pdf?origin=publication_list
[4] Chee CB, Teleman MD, Boudville IC, et al. Treatment of latent TB infection for close contacts as a complementary TB control strategy in Singapore. Int J Tuberclung D, 2004; 8, 226-31. http://med.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_PM15139452
[5] Denholm JT, Mcbryde ES. Management of Latent Tuberculosis Infections in Australia and New Zealand: A Review of Current Practice. Tuberc Res Treat, 2010; 2010. http://cn.bing.com/academic/profile?id=65fd7a4646febe6876e7fc940e682710&encoded=0&v=paper_preview&mkt=zh-cn
[6] Stagg HR, Zenner D, Harris RJ, et al. Treatment of latent tuberculosis infection: a network meta-analysis. AM J Resp Crit Care, 2014; 162, 394-5. http://cn.bing.com/academic/profile?id=cca255feb40d11244d5fae19c1bc3fc6&encoded=0&v=paper_preview&mkt=zh-cn
[7] Cass AD, Talawera GA, Gresham LS, et al. Structured behavioral intervention to increase children's adherence to treatment for latent tuberculosis infection. Int J Tuberclung D, 2005; 9, 415. http://europepmc.org/abstract/MED/15830747
[8] World Health Organization. Guidelines on the management of latent tuberculosis infection. http://www.who.int/tb/publications/latent-tuberculosis-infection/en/ [2017/2/20]
[9] Zhao Y, Ehiri J, Li D, et al. A survey of TB knowledge among medical students in Southwest China: is the information reaching the target? BMJ Open, 2013; 3. https://www.researchgate.net/profile/John_Ehiri/publication/256930236_A_survey_of_TB_knowledge_among_medical_students_in_Southwest_China_is_the_information_reaching_the_target/links/00b49536170a3b6b94000000.pdf
[10] Denholm JT, Mcbryde ES, Eisen DP, et al. Adverse effects of isoniazid preventative therapy for latent tuberculosis infection: a prospective cohort study. Drug Healthc Patient Saf, 2014; 6, 145. https://www.researchgate.net/profile/Emma_Mcbryde3/publication/267754357_Adverse_effects_of_isoniazid_preventative_therapy_for_latent_tuberculosis_infection_A_prospective_cohort_study/links/55c840ee08aeb9756746fa82/Adverse-effects-of-isoniazid-preventative-therapy-for-latent-tuberculosis-infection-A-prospective-cohort-study.pdf
[11] Spyridis NP, Spyridis PG, Gelesme A, et al. The Effectiveness of a 9-Month Regimen of Isoniazid Alone versus 3- and 4-Month Regimens of Isoniazid plus Rifampin for Treatment of Latent Tuberculosis Infection in Children: Results of an 11-Year Randomized Study. Clin Infect Dis, 2007; 45, 715-22. doi:  10.1086/520983
[12] Spyridis NP, Spyridis PG, Gelesme A, et al. The Effectiveness of a 9-Month Regimen of Isoniazid Alone versus 3- and 4-Month Regimens of Isoniazid plus Rifampin for Treatment of Latent Tuberculosis Infection in Children: Results of an 11-Year Randomized Study. Clin Infect Dis, 2007; 45, 715-22. doi:  10.1086/520983